Equity (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended			9 Months Ended
	Mar. 31, 2023	Jan. 31, 2023	Aug. 31, 2018	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of common stock to Regeneron, net of issuance costs				$ 0	$ 9,859
Common stock				$ 5		$ 5
Underwritten Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of shares issued in transaction (in shares)	10,869,566
Common stock price per share (in dollars per share)	$ 11.50
Aggregate net proceeds	$ 117,000
Additional shares available for purchase (in shares)	1,630,434
Regeneron | Share Purchase Agreement
Subsidiary, Sale of Stock [Line Items]
Common stock shares issued (in shares)		1,114,827	100,000
Proceeds from issuance of common stock to Regeneron, net of issuance costs		$ 20,000
Common stock		9,900
Contract with customer liability		$ 10,100
Common stock price per share (in dollars per share)		$ 17.94